With a proven track record in driving revenue growth and executing ... for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour,” European Journal of Cancer 141:162-170, 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback